Medicare Drug Plans Are Hiking Premiums While Trump Claims Victory on Medicine Prices
Millions of Medicare enrollees who buy stand-alone prescription drug plans will see their average monthly…
Medicare Drug Plans Are Hiking Premiums While Trump Claims Victory on Medicine Prices
Millions of Medicare enrollees who buy stand-alone prescription drug plans will see their average monthly premiums rise by 50% in 2027, a new analysis finds. But enrollees can avoid the average increase — from $34 a month to $51 — by switching to lower-cost plans during the program’s open enrollment period, which runs through Dec….
For Californians Drowning in Healthcare Costs, Governor’s Race Offers Few Answers
When Ashley Porter began slurring her speech one October day four years ago, doctors suspected a stroke. A spinal tap, an MRI, dozens of blood draws, another MRI, and a night spent at the hospital were followed, finally, by an answer: Porter had multiple sclerosis. Her shock turned to outrage, she said, when she received…
Your Phone Knows You’re at the Doctor, and Data Brokers Do, Too — Then Profit From It
Chris McQueen finished treatment for leukemia a year and a half ago, but the ads for fake cures never stopped. Juice cleanses to cure cancer, “natural” cancer treatments, clinics in Mexico promising full recovery with little chemotherapy — all appeared on McQueen’s mobile phone during routine oncologist visits and monthly bloodwork. McQueen and others have…
Frights, Fangs, and Healthcare Nightmares in Winning Halloween Haikus
What’s scarier than ghosts and goblins? How about measles, unaffordable dental care, and an insurance claim denied by artificial intelligence? Nearly 80 healthcare-themed haikus crept into our inbox this Halloween season. Meet the winners of KFF Health News’ eighth annual Halloween haiku contest below. Follow KFF Health News’ social media accounts (X, Instagram, and Facebook)…
Medicare Part D Premiums and Cost Sharing in 2027
Medicare Part D is a voluntary outpatient prescription drug benefit for people with Medicare provided through private plans, including stand-alone prescription drug plans and Medicare Advantage plans that offer drug coverage. This analysis provides an overview of Medicare Part D premiums and cost sharing in 2027 and key trends over time.
The Average Monthly Premium for Medicare Part D Stand-Alone Plans Is Projected to Increase by 50% From $34 to $51 in 2027 Unless Enrollees Switch to Lower-Cost Plans
A new KFF analysis finds that the average monthly premium for Medicare Part D coverage in stand-alone prescription drug plans (PDPs) will increase to $51 in 2027, up 50% from $34 in 2026, if current enrollees don’t switch into lower-premium plans during open enrollment, which runs through December 7.
2026 Mid-terms: Voting for the Future
By MIKE MAGEE This week, New York Times political columnist, Linda Kindler reflected on “How Silicon Valley Stole the Future.” Signaling that this wasn’t simply another article on the binary choices of an AI world – or as she put it “either a world in which A.I. has eliminated all jobs, unleashed bioengineered viruses and…
What’s Driving the Rise of Consumer Diagnostics?
At MedCity INVEST Digital Health, experts from Jona, Labcorp and Evvy discussed the drivers of consumer diagnostics. The post What’s Driving the Rise of Consumer Diagnostics? appeared first on MedCity News.
BioMarin Expands Again in Enzyme Replacement, Paying $70M for Long-Acting Fabry Drug
BioMarin gains rights to a Fabry disease enzyme replacement therapy with potential dosing advantages over products from Sanofi and Chiesi Group. BioMarin’s new clinical-stage asset could reach patients ineligible for the Fabry drug that came with its Amicus Therapeutics acquisition earlier this year. The post BioMarin Expands Again in Enzyme Replacement, Paying $70M for Long-Acting…
MedStar Navigates Roll-Out of Electronic Patient-Reported Outcomes
MedStar’s Hannah Arem, Ph.D., M.P.H., stresses need to integrate viewpoints of leadership, clinicians, frontline staff, patients, and caregivers
